Tuning the Selectivity of Dendron Micelles Through Variations of the Poly(ethylene glycol) Corona
Source abstract
Abstract
Engineering controllable cellular interactions into nanoscale drug delivery systems is key to enable their full potential. Here, using folic acid (FA) as a model targeting ligand and dendron micelles (DM) as a nanoparticle (NP) platform, we present a comprehensive experimental and modeling investigation of the structural properties of DMs that govern the formation of controllable, FA-mediated cellular interactions. Our experimental results demonstrate that a high level of control over the specific cell interactions of FA-targeted DMs can be achieved through modulation of the PEG corona length and the FA content. Using various molecular weight PEGs (0.6K, 1K, and 2K g/mol) and contents of dendron-FA conjugate incorporated into DMs (0, 5, 10, 25 wt %), the cell interactions of the targeted DMs could be controlled to exhibit minimal to >25-fold enhancement over nontargeted DMs. Molecular dynamics simulations indicated that structural characteristics, such as solvent accessible surface area of FA, local PEG density near FA, and FA mobility, account in part for the experimental differences in cellular interactions. The molecular structure that allows FA to depart from the surface of DMs to facilitate the initial cell surface binding was revealed to be the most important contributor for determining FA-mediated cellular interactions of DMs. The modular properties of DMs in controlling their specific cell interactions support the potential of DMs as a delivery platform and offer design cues for future development of targeted NPs.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
Funding
National Cancer Institute · Camille and Henry Dreyfus Foundation · Alex's Lemonade Stand Foundation for Childhood Cancer · Leukemia and Lymphoma Society · Division of Materials Research · University of Illinois at Chicago · Hans W. Vahlteich Research Fund, University of Illinois at Chicago · College of Liberal Arts and Sciences, University of Illinois at Chicago
References (45)
Show source-provided references
1. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
2. 10.4155/tde.12.7610.4155/tde.12.76 ↗
3. 10.1557/mrs.2014.910.1557/mrs.2014.9 ↗
4. 10.1016/j.ijpharm.2005.10.01010.1016/j.ijpharm.2005.10.010 ↗
5. 10.1021/ja208433810.1021/ja2084338 ↗
6. 10.1021/nl302638g10.1021/nl302638g ↗
7. 10.3389/fchem.2014.0010810.3389/fchem.2014.00108 ↗
8. 10.1016/j.addr.2008.08.00510.1016/j.addr.2008.08.005 ↗
9. 10.1038/nrd261410.1038/nrd2614 ↗
10. 10.1021/bc980112410.1021/bc9801124 ↗
11. 10.1021/nn301630n10.1021/nn301630n ↗
12. 10.1021/nn305663e10.1021/nn305663e ↗
13. 10.1080/1061186080223024010.1080/10611860802230240 ↗
14. Lee R. J. · J. Biol. Chem. · 1994 · 269 · 319810.1016/S0021-9258(17)41848-5 ↗
15. 10.1016/j.addr.2004.01.01110.1016/j.addr.2004.01.011 ↗
16. 10.1158/1078-0432.CCR-08-015910.1158/1078-0432.CCR-08-0159 ↗
17. 10.1021/nn403395410.1021/nn4033954 ↗
18. 10.1039/c1cc14331j10.1039/c1cc14331j ↗
19. 10.1021/mz300533w10.1021/mz300533w ↗
20. 10.1021/ma501258c10.1021/ma501258c ↗
21. 10.1002/anie.20151173310.1002/anie.201511733 ↗
22. 10.1016/j.chembiol.2006.11.01510.1016/j.chembiol.2006.11.015 ↗
23. 10.1002/anie.20110550810.1002/anie.201105508 ↗
24. 10.1002/anie.20100344510.1002/anie.201003445 ↗
25. 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S ↗
26. Weitman S. D. · Cancer Res. · 1992 · 52 · 3396
27. 10.1016/S0169-409X(99)00062-910.1016/S0169-409X(99)00062-9 ↗
28. 10.1021/bm300316n10.1021/bm300316n ↗
29. 10.1021/mp300560n10.1021/mp300560n ↗
30. 10.1021/acs.molpharmaceut.5b0094610.1021/acs.molpharmaceut.5b00946 ↗
31. 10.1021/mp500096710.1021/mp5000967 ↗
32. 10.1038/nature1232710.1038/nature12327 ↗
33. 10.1016/j.biomaterials.2011.04.07810.1016/j.biomaterials.2011.04.078 ↗
34. 10.1126/science.275.5301.82010.1126/science.275.5301.820 ↗
35. Beer J. H. · Blood · 1992 · 79 · 11710.1182/blood.V79.1.117.117 ↗
36. 10.1038/nnano.2012.23710.1038/nnano.2012.237 ↗
37. 10.1002/anie.20130946410.1002/anie.201309464 ↗
38. 10.1021/acsnano.5b0132610.1021/acsnano.5b01326 ↗
39. 10.1002/jbm.a.3153710.1002/jbm.a.31537 ↗
40. 10.1002/jcc.2028910.1002/jcc.20289 ↗
41. 10.1021/jp973084f10.1021/jp973084f ↗
42. 10.1529/biophysj.108.13302510.1529/biophysj.108.133025 ↗
43. 10.1002/jcc.2136710.1002/jcc.21367 ↗
44. 10.1002/andp.1921369030410.1002/andp.19213690304 ↗
45. 10.1016/0263-7855(96)00018-510.1016/0263-7855(96)00018-5 ↗